Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
Kartoon Studios	TOON	11. nov 2024	0.79	-1.16
Karyopharm Therapeutics	KPTI	11. nov 2024	0.92	+5.13
Katapult	KPLT	11. nov 2024	6.91	+1.47
Kayne Anderson BDC	KBDC	11. nov 2024	16.50	-0.06
Kayne Anderson Energy Infrastructure Fund	KYN	11. nov 2024	12.89	+0.62
Kazia Therapeutics ADR	KZIA	11. nov 2024	6.78	+18.12
KB Financial Group ADR	KB	11. nov 2024	66.19	+0.21
KB Home	KBH	11. nov 2024	82.79	+0.72
KBR	KBR	11. nov 2024	72.02	+0.60
KBW Bank Powershares	KBWB	11. nov 2024	69.30	+2.36
KBW High Div Yield Financial Powershares	KBWD	11. nov 2024	15.42	+0.65
KBW Prem Yield Equity REIT Powershares	KBWY	11. nov 2024	20.15	-0.30
KBW Prop & Casuality Insur Powershares	KBWP	11. nov 2024	120.90	+0.51
KBW Regional Banking Powershares	KBWR	11. nov 2024	66.66	+2.92
KE Holdings	BEKE	11. nov 2024	21.22	+1.10
Kearny Financial	KRNY	11. nov 2024	8.48	+4.56
Keen Vision Acquisition	KVACU	11. nov 2024	10.89	+0.09
Keen Vision Acquisition	KVAC	11. nov 2024	10.87	0.00
Kellanova	K	11. nov 2024	81.10	+0.12
Kelly Services A	KELYA	11. nov 2024	16.23	-1.76
Kelly Services B	KELYB	11. nov 2024	16.48	0.00
Kemper	KMPR	11. nov 2024	68.66	+1.24
Kennametal	KMT	11. nov 2024	30.09	+2.07
Kennedy-Wilson	KW	11. nov 2024	11.70	+1.47
Kenon Holdings	KEN	11. nov 2024	28.74	+0.57
Kentucky First Federal Bancorp	KFFB	11. nov 2024	2.52	+0.40
Kenvue	KVUE	11. nov 2024	23.78	+0.42
Keros Therapeutics	KROS	11. nov 2024	68.15	+0.35
Keurig Dr Pepper	KDP	11. nov 2024	33.20	+0.97
Kewaunee Scientific	KEQU	11. nov 2024	37.60	-0.29

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.